Excitingly, the pharmacological inhibition of TyrRS from entering the nucleus using the PCAF inhibitor embelin mimicked the effect of the genetic restriction and rescued specific disease features in the CMT fly, showing for the first time a successful therapeutic intervention for TyrRS-induced peripheral neuropathy. Here, YARS1 is linked to peripheral neuropathy.